Nicholas Muzyczka

Nicholas Muzyczka's AcademicInfluence.com Rankings

Nicholas Muzyczka

Engineering

#6273

World Rank

#7589

Historical Rank

Bioengineering

#66

World Rank

#68

Historical Rank

Applied Physics

#1976

World Rank

#2011

Historical Rank

engineering Degrees

Download Badge

Engineering

Nicholas Muzyczka's Degrees

Bachelors Bioengineering University of California, Berkeley
PhD Bioengineering University of California, Berkeley

Why Is Nicholas Muzyczka Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Nicholas Muzyczka's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield (1999) (1247)
Use of adeno-associated virus as a general transduction vector for mammalian cells. (1992) (771)
Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. (2004) (725)
Parkinson-Like Neurodegeneration Induced by Targeted Overexpression of α-Synuclein in the Nigrostriatal System (2002) (682)
A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells (1996) (648)
Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. (2002) (553)
Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses (2008) (511)
The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity (1990) (470)
Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. (1984) (438)
Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. (1982) (422)
Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. (1997) (399)
Mutational Analysis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Construction of AAV2 Vectors with Altered Tropism (2000) (383)
Adeno-associated virus general transduction vectors: analysis of proviral structures (1988) (367)
AAV-Mediated Gene Therapy for Research and Therapeutic Purposes. (2014) (344)
Identification of Amino Acid Residues in the Capsid Proteins of Adeno-Associated Virus Type 2 That Contribute to Heparan Sulfate Proteoglycan Binding (2003) (332)
Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. (1998) (305)
Nigrostriatal α-synucleinopathy induced by viral vector-mediated overexpression of human α-synuclein: A new primate model of Parkinson's disease (2003) (305)
Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants (1984) (294)
Rescue of adeno-associated virus from recombinant plasmids: Gene correction within the terminal repeats of AAV (1983) (293)
Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters (1997) (283)
The phosphorylation state of Ser-129 in human α-synuclein determines neurodegeneration in a rat model of Parkinson disease (2008) (280)
Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors (2001) (267)
Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78 (2010) (267)
Neuron-Specific Transduction in the Rat Septohippocampal or Nigrostriatal Pathway by Recombinant Adeno-associated Virus Vectors (1998) (255)
Site-specific integration by adeno-associated virus. (1990) (244)
Continuous Low-Level Glial Cell Line-Derived Neurotrophic Factor Delivery Using Recombinant Adeno-Associated Viral Vectors Provides Neuroprotection and Induces Behavioral Recovery in a Primate Model of Parkinson's Disease (2005) (231)
Studies on the biochemical basis of spontaneous mutation. I. A comparison of the deoxyribonucleic acid polymerases of mutator, antimutator, and wild type strains of bacteriophage T4. (1972) (227)
Structure of Adeno-Associated Virus Serotype 8, a Gene Therapy Vector (2007) (212)
Circulating Anti-Wild-Type Adeno-Associated Virus Type 2 (AAV2) Antibodies Inhibit Recombinant AAV2 (rAAV2)-Mediated, but Not rAAV5-Mediated, Gene Transfer in the Brain (2004) (212)
Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression. (2008) (204)
The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection (1997) (200)
Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain. (2007) (193)
Myosin IIb Regulates Actin Dynamics during Synaptic Plasticity and Memory Formation (2010) (189)
Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization (1992) (188)
Adeno-Associated Virus Type 2 VP2 Capsid Protein Is Nonessential and Can Tolerate Large Peptide Insertions at Its N Terminus (2004) (184)
Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults. (2006) (180)
Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein (1994) (174)
Structurally Mapping the Diverse Phenotype of Adeno-Associated Virus Serotype 4 (2006) (171)
In vitro resolution of covalently joined AAV chromosome ends (1990) (170)
Factors that bind to adeno-associated virus terminal repeats (1989) (166)
Development of in vivo gene therapy for hearing disorders: introduction of adeno-associated virus into the cochlea of the guinea pig. (1996) (164)
High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap (1999) (160)
Glucose regulated protein 78 diminishes α-synuclein neurotoxicity in a rat model of Parkinson disease. (2012) (148)
Evidence for covalent attachment of the adeno-associated virus (AAV) rep protein to the ends of the AAV genome (1990) (147)
[48] Production and purification of recombinant adeno-associated virus (2000) (146)
Adenovirus-Facilitated Nuclear Translocation of Adeno-Associated Virus Type 2 (2002) (145)
In vitro replication of adeno-associated virus DNA (1994) (145)
Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of l-dopa using rAAV-mediated gene transfer (2002) (145)
Structural Insight into the Unique Properties of Adeno-Associated Virus Serotype 9 (2012) (143)
Features of the adeno-associated virus origin involved in substrate recognition by the viral Rep protein (1993) (140)
Prevention of 6-hydroxydopamine-induced rotational behavior by BDNF somatic gene transfer (1999) (134)
Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice. (1999) (132)
In Vivo RNAi-Mediated α-Synuclein Silencing Induces Nigrostriatal Degeneration. (2010) (130)
Studies on the biochemical basis of spontaneous mutation. II. The incorporation of a base and its analogue into DNA by wild-type, mutator and antimutator DNA polymerases. (1974) (128)
In vivo RNAi-mediated alpha-synuclein silencing induces nigrostriatal degeneration. (2010) (127)
Sequence requirements for binding of Rep68 to the adeno-associated virus terminal repeats (1996) (125)
OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy. (2014) (124)
Interaction of the adeno-associated virus Rep protein with a sequence within the A palindrome of the viral terminal repeat (1994) (121)
Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system. (2005) (119)
Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver (2003) (118)
Structure and Dynamics of Adeno-Associated Virus Serotype 1 VP1-Unique N-Terminal Domain and Its Role in Capsid Trafficking (2013) (118)
Sequences required for coordinate induction of adeno-associated virus p19 and p40 promoters by Rep protein (1991) (113)
Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve. (1999) (112)
Structure of Adeno-Associated Virus Type 4 (2005) (111)
Cellular Proteins Required for Adeno-Associated Virus DNA Replication in the Absence of Adenovirus Coinfection (1998) (110)
Time course of transgene expression after intrastriatal pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 transduction in the rat. (2007) (110)
Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap (1997) (109)
Heparin binding induces conformational changes in Adeno-associated virus serotype 2. (2009) (109)
Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus. (2002) (108)
Production and purification of recombinant adeno-associated virus. (2000) (107)
Mechanism of Rep-Mediated Adeno-Associated Virus Origin Nicking (2000) (99)
Capsid Antibodies to Different Adeno-Associated Virus Serotypes Bind Common Regions (2013) (97)
Nigrostriatal rAAV-mediated GDNF overexpression induces robust weight loss in a rat model of age-related obesity. (2009) (97)
Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virus (1998) (96)
Patterns of Gene Expression Reveal a Temporally Orchestrated Wound Healing Response in the Injured Spinal Cord (2004) (94)
Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study (2001) (94)
Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus) (2003) (93)
Rep-Mediated Nicking of the Adeno-Associated Virus Origin Requires Two Biochemical Activities, DNA Helicase Activity and Transesterification (1999) (87)
Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors. (2005) (87)
Biochemical Characterization of Adeno-Associated Virus Rep68 DNA Helicase and ATPase Activities (1999) (86)
Suppression of Insult-Induced Neurogenesis in Adult Rat Brain by Brain-Derived Neurotrophic Factor (2002) (85)
Long-term actions of vector-derived nerve growth factor or brain-derived neurotrophic factor on choline acetyltransferase and Trk receptor levels in the adult rat basal forebrain (1999) (84)
Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism. (2005) (81)
Structural Studies of Adeno-Associated Virus Serotype 8 Capsid Transitions Associated with Endosomal Trafficking (2011) (80)
Altering AAV tropism with mosaic viral capsids. (2005) (78)
Changes in transcription within the CA1 field of the hippocampus are associated with age-related spatial learning impairments (2007) (77)
The cellular transcription factor SP1 and an unknown cellular protein are required to mediate Rep protein activation of the adeno-associated virus p19 promoter (1997) (77)
NGF gene transfer to intrinsic basal forebrain neurons increases cholinergic cell size and protects from age-related, spatial memory deficits in middle-aged rats (2000) (76)
Neuropathological and Behavioral Consequences of Adeno-Associated Viral Vector-Mediated Continuous Intrastriatal Neurotrophin Delivery in a Focal Ischemia Model in Rats (2002) (73)
Analysis of mutations in adeno-associated virus Rep protein in vivo and in vitro (1992) (72)
AAV: An Overview of Unanswered Questions. (2017) (71)
Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectors. (2014) (71)
Adeno-associated virus-mediated aspartoacylase gene transfer to the brain of knockout mouse for canavan disease. (2003) (71)
Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma? (2015) (70)
Identification of Cellular Proteins That Interact with the Adeno-Associated Virus Rep Protein (2008) (70)
Complete In Vitro Reconstitution of Adeno-Associated Virus DNA Replication Requires the Minichromosome Maintenance Complex Proteins (2007) (68)
rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease (2007) (67)
Green fluorescent protein as a reporter for gene transfer studies in the cochlea (1997) (66)
Cre‐mediated recombination in the pituitary gland (2000) (64)
Tight Long-term dynamic doxycycline responsive nigrostriatal GDNF using a single rAAV vector. (2009) (63)
Structural Insights into Adeno-Associated Virus Serotype 5 (2013) (62)
Expression of adeno-associated virus integrated transgene within the mammalian vestibular organs. (1998) (62)
Gene therapy delivery of endostatin enhances the treatment efficacy of radiation. (2003) (61)
Evidence for pH-Dependent Protease Activity in the Adeno-Associated Virus Capsid (2012) (60)
Regulated high-level human beta-globin gene expression in erythroid cells following recombinant adeno-associated virus-mediated gene transfer. (1995) (58)
Long-term differential modulation of genes encoding orexigenic and anorexigenic peptides by leptin delivered by rAAV vector in ob/ob mice Relationship with body weight change (2000) (58)
Genome-wide analysis of aging and learning-related genes in the hippocampal dentate gyrus (2008) (57)
Adeno-Associated Virus Serotype 1 (AAV1)- and AAV5-Antibody Complex Structures Reveal Evolutionary Commonalities in Parvovirus Antigenic Reactivity (2014) (55)
Adeno-Associated Virus Capsid Proteins May Play a Role in Transcription and Second-Strand Synthesis of Recombinant Genomes (2013) (54)
Adeno-associated virus–mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo (2002) (52)
Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 1. (2006) (51)
The adeno-associated virus type 2 p40 promoter requires a proximal Sp1 interaction and a p19 CArG-like element to facilitate Rep transactivation (1997) (51)
Studies on the biochemical basis of spontaneous mutation. III. Rate model for DNA polymerase-effected nucleotide misincorporation. (1974) (47)
Streamlined large-scale production of recombinant adeno-associated virus (rAAV) vectors. (2002) (47)
Striatal readministration of rAAV vectors reveals an immune response against AAV2 capsids that can be circumvented. (2009) (46)
In Vitro Packaging of Adeno-Associated Virus DNA (1998) (44)
Adeno-associated viral (AAV) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces Abeta deposits in APP + PS1 transgenic mice. (2008) (43)
Purification of Host Cell Enzymes Involved in Adeno-Associated Virus DNA Replication (2007) (42)
In vitro excision of adeno-associated virus DNA from recombinant plasmids: isolation of an enzyme fraction from HeLa cells that cleaves DNA at poly(G) sequences (1988) (40)
Production, purification, crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 5. (2005) (39)
α-Synuclein expression in rat substantia nigra suppresses phospholipase D2 toxicity and nigral neurodegeneration. (2010) (39)
Differential modulation of energy balance by leptin, ciliary neurotrophic factor, and leukemia inhibitory factor gene delivery: microarray deoxyribonucleic acid-chip analysis of gene expression. (2004) (39)
Enhanced Transgene Expression from Recombinant Single-Stranded D-Sequence-Substituted Adeno-Associated Virus Vectors in Human Cell Lines In Vitro and in Murine Hepatocytes In Vivo (2014) (33)
The genetics of adeno-associated virus. (1984) (32)
Cryo-electron Microscopy Reconstruction and Stability Studies of the Wild Type and the R432A Variant of Adeno-associated Virus Type 2 Reveal that Capsid Structural Stability Is a Major Factor in Genome Packaging (2016) (31)
Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 9. (2009) (30)
Gene therapy for murine mucopolysaccharidosis type VII (1997) (30)
The Adeno-Associated Virus Genome Packaging Puzzle. (2015) (30)
Characterization of the adenoassociated virus Rep protein complex formed on the viral origin of DNA replication. (2003) (29)
Characterization of recombinant adeno-associated virus-2 as a vehicle for gene delivery and expression into vascular cells. (1997) (28)
Production, purification, crystallization and preliminary X-ray analysis of adeno-associated virus serotype 8. (2005) (28)
The Effect of DNA-Dependent Protein Kinase on Adeno-Associated Virus Replication (2010) (28)
Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 7. (2007) (27)
Viral Expression Vectors (2011) (26)
Mutants at the 2-Fold Interface of Adeno-associated Virus Type 2 (AAV2) Structural Proteins Suggest a Role in Viral Transcription for AAV Capsids (2016) (25)
Adeno-associated virus (AAV) vectors: will they work? (1994) (25)
Generation of aberrant sprouting in the adult rat brain by GAP-43 somatic gene transfer (1999) (25)
Enhanced expression of Pctk1, Tcf12 and Ccnd1 in hippocampus of rats: Impact on cognitive function, synaptic plasticity and pathology (2012) (24)
Studies of the Mechanism of Transactivation of the Adeno-Associated Virus p19 Promoter by Rep Protein (2002) (24)
Hypothalamic rAAV-mediated GDNF gene delivery ameliorates age-related obesity (2006) (24)
7 Adeno-associated Viral Vectors (1999) (21)
AAV's Golden Jubilee. (2015) (20)
Construction of a specific amber codon in the simian virus 40 T-antigen gene by site-directed mutagenesis (1980) (19)
An animal model of PDH deficiency using AAV8-siRNA vector-mediated knockdown of pyruvate dehydrogenase E1α. (2010) (17)
Adeno-associated Viral (AAV) Serotype 5 Vector Mediated Gene Delivery of Endothelin-converting Enzyme Reduces Aβ Deposits in APP + PS1 Transgenic Mice. (2008) (15)
Developing VDEPT for DT-diaphorase (NQO1) using an AAV vector plasmid. (1998) (14)
Purification and characterization of HeLa endonuclease R. A G-specific mammalian endonuclease. (1990) (14)
CLONING OF AAV INTO pBR322: RESCUE OF INTACT VIRUS FROM THE RECOMBINANT PLASMID IN HUMAN CELLS (1982) (13)
Bacteriophage T5 growth in Escherichia coli containing cloned PstI fragments of the colicin Ib plasmid (1981) (12)
Construction of an SV40-derived cloning vector. (1980) (11)
Adeno-associated virus vector-mediated gene transfer to somatic cells in the central nervous system. (2000) (11)
Charge-to-Alanine Mutagenesis of the Adeno-Associated Virus Type 2 Rep78/68 Proteins Yields Temperature-Sensitive and Magnesium-Dependent Variants (2000) (10)
Substrate specificity of HeLa endonuclease R. A G-specific mammalian endonuclease. (1990) (10)
Utilization of aminopurine deoxynucleoside triphosphate by mutator, antimutator and wild-type DNA polymerases of bacteriophage T4. (1973) (9)
Efficacy of recombinant adeno-associated viral vectors serotypes 1, 2, and 5 for the transduction of pancreatic and colon carcinoma cells. (2010) (9)
Adeno‐Associated Virus Rep78/Rep68 Promotes Localized Melting of the Rep Binding Element in the Absence of Adenosine Triphosphate (2004) (9)
Persistence of phage lambda DNA in genomes of mouse cells transformed by lambda-carrying SV40 vectors. (1979) (7)
Transcytosis in the blood–cerebrospinal fluid barrier of the mouse brain with an engineered receptor/ligand system (2015) (7)
Biodistribution of Adeno-Associated Virus Type 2 with Mutations in the Capsid that Contribute to Heparan Sulfate Proteoglycan Binding. (2019) (7)
The Lipase Activity of Phospholipase D2 is Responsible for Nigral Neurodegeneration in a Rat Model of Parkinson’s Disease (2018) (6)
Characterization of am404, an amber mutation in the simian virus 40 T antigen gene (1983) (6)
Recombinant adeno-associated and adenoviral vectors for the transduction of pancreatic and colon carcinoma. (2006) (5)
Charge-to-Alanine Mutagenesis of the Adeno-Associated Virus Type 2 Rep78/68 Proteins Yields Temperature-Sensitive and Magnesium-Dependent Variants (1999) (5)
59. rAAV-Mediated Nigral Parkin Over-Expression Is Neuroprotective in the 6-OHDA Rat Model of Parkinson's Disease (2005) (4)
Restriction endonuclease mapping of the colicin Ib plasmid (1982) (4)
Manufacture and Stability of the Recombinant Adeno-Associated Virus Serotype 2 Vector Reference Standard (2008) (4)
Construction, expression, and purification of recombinant αVβ5 integrin. (2013) (3)
Partial Purification ofAdeno-Associated VirusRep78,Rep52,and Rep4OandTheirBiochemical Characterization (1992) (3)
Comparison of the DNA sequence and secondary structure of the herpes simplex virus L/S junction and the adeno-associated virus terminal repeat. (1985) (3)
Molecular cloning, overexpression, and an efficient one-step purification of α5β1 integrin. (2013) (2)
Adeno-Associated Viral (AAV) Vectors (2010) (2)
400. Successful Production of Pseudotyped Mosaic rAAV Vectors Using a Modified Baculovirus Expression System (2005) (2)
Adeno-associated virus mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo (2003) (2)
Chapter 17:Viral Vectors for Gene Delivery (2010) (1)
162. Crossing the Blood-Cerebrospinal Fluid Barrier in the Mouse Choroid Plexus With an Engineered Receptor/Ligand System (2015) (1)
recombinant AAV vectors in human cell lines in vitro and in murine hepatocytes in (2014) (1)
Bacteriophage T5 growth in Escherichia coli containing PstI fragments of the colicin Ib plasmid. (1981) (1)
Activation of the Unfolded Protein Response in a Rat Model of ADRP (2010) (0)
Tailoring of the AAV capsid: designing the second generation vector (2005) (0)
420. Adaptation of Baculovirus System for Large-Scale Production of rAAV Vector Serotypes (2004) (0)
10 Adeno-associated virus-mediated knockdown of pyruvate dehydrogenase E1αα in specific regions of the rat brain (2010) (0)
Structural Characterization of Adeno-Associated Virus Serotype 9 (2012) (0)
ends of the AAV genome. the adeno-associated virus (AAV) rep protein to Evidence for covalent attachment of the (2013) (0)
Structure and dynamics of Adeno-Associated Virus 1 serotype 1 VP 1-unique N-terminal domain and its role in 2 capsid trafficking (2013) (0)
Structural insights of Adeno-Associated virus 5. A gene therapy Vector for Cystic Fibrosis (2011) (0)
Construction of a recombinant adenoassociated virus aav vector carrying the cystic fibrosis cdna (1992) (0)
Structure of the R432A variant of Adeno-associated virus type 2 VLP (2016) (0)
Viral mediated retinal expression of a synthetic green fluorescent protein cDNA (1996) (0)
a-synucleinopathy induced by recombinant AAV vector-mediated overexpression of human a-synuclein : A new primate model of Parkinson ’ s disease (2002) (0)
Structural Studies of Adeno-Associated Virus Serotype 8 Capsid Transitions Associated with Endosomal Trafﬁcking (cid:1) (2011) (0)
95. Incorporation of AAV Serotype 2 Viral Protein 2 into Other AAV Serotype Capsids (2016) (0)
1082. Transduction Comparison of AAV Serotype Vectors in the Central Nervous System (2005) (0)
Analysis ofMutations inAdeno-Associated Virus Rep (1992) (0)
Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides anatomical and behavioural protection against 6-OHDA lesions in the common marmoset monkey (Callithrix jacchus) (2003) (0)
Structural Rearrangements in R432A Variant of AAV2 Affect Genome Packaging (2016) (0)
Reversal of L-DOPA-induced dyskinesia by recombinant AAV-mediated gene transfer (2004) (0)
Production de virions de virus adeno-associe (aav) recombinants pseudo-types (2003) (0)
Virus Serotype 5 Structural Insights into Adeno-Associated (2014) (0)
Adeno-associated viral mediated transfer of the Lac Z reporter gene in the optic nerve and retina of the guinea pig (1996) (0)
AAV for disorders of the CNS (2005) (0)
Useofadeno-associated virus asamammalian DNA cloning vector: Transduction ofneomycin resistance intomammalian (1984) (0)
Patent Number : ( 45 ) Date of Patent : 5 , 139 , 941 Aug . 18 , 1992 ( 54 AAV TRANSDUCTION VECTORS 75 Inventors : (2017) (0)
" Verdohemochrome IXa : Preparation and oxidoreductive cleavage to biliverdin IXa (2003) (0)
Humanized green-fluorescent protein and methods (1997) (0)
Structure to Function Correlations for Adeno-associated Virus Serotype 1 (2011) (0)
Structure of Adeno-associated virus type 2 VLP (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Nicholas Muzyczka?

Nicholas Muzyczka is affiliated with the following schools:

Nicholas Muzyczka's Academic­Influence.com Rankings

Nicholas Muzyczka's Degrees

Why Is Nicholas Muzyczka Influential?

Nicholas Muzyczka's Published Works

Published Works

What Schools Are Affiliated With Nicholas Muzyczka?

Nicholas Muzyczka's AcademicInfluence.com Rankings